OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference

Announcement on the Change of Chief Financial Officer
March 9, 2018
FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors
April 19, 2018

1. Date of the event: 2018/03/21
2. Time: 08:30:00 TST
3. Location:Conrad Hong Kong
4. Summary: OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference
5. Any other matters that need to be specified: None

Please refer to MOPS for detail financial information regarding the event.